CTOs on the Move


 
BTP is a Hamilton, ON-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.btp.on.ca
  • 86 Bowman St
    Hamilton, ON CAN L8S 2T6
  • Phone: 905.572.6259

Executives

Name Title Contact Details

Similar Companies

Securicy

A platform that provides organizations with the tools to build, maintain, and enforce cyber security policies and procedures that adhere to established cyber security standards.

Icertis

Icertis, the leading provider of enterprise contract management in the cloud, solves the hardest contract management problems on the easiest to use platform. Icertis helps companies transform their commercial foundation ensuring compliance, improving governance, mitigating risk and enhancing user productivity, thereby improving the bottom line. The Icertis Contract Management (ICM) platform is used by 1+ million users at companies like 3M, Abbvie, Cognizant, Daimler, and Microsoft, to manage 3.5+ million contracts in 40+ languages across 90+ countries. Todd joins Icertis from the enterprise software-as-a-service (SaaS) company, Apptio, where he helped lead the company from its early days through its highly successful initial public offering and beyond. Before joining Apptio, Todd was a Partner at Cairncross & Hempelmann where he led the Technology Transactions practice group and advised many Seattle-area startups and Fortune 500 clients.

Flex

Flex is a simple app that`s changing the way the world pays and collects rent. Our technology makes the 1st of the month easy for renters and properties.

Strategic Information Technology

Strategic Information Technology provides banking software for banks, credit unions, trust companies, loan companies, insurance companies, and more. Portfolio Plus is the flagship product and it includes functionality for loans, mortgages, investments, term deposits, retail banking, and more.

IPM.ai

IPM.ai transforms RWD via AI to uncover the ideal patient population so pharmaceutical can commercialize therapies for specialty and rare disease